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Abstract
During pregnancy and involution, an extensive remodelling of the human cervical connective tissue occurs. This cervical
ripening is one of the most pronounced physiological remodelling processes known in human connective tissue. To
investigate how the remodelling is accomplished, the levels of mRNA for collagen I and III, versican and three small
proteoglycans, biglycan, decorin and fibromodulin, were evaluated using Northern blots at different stages of cervical
ripening. In the corresponding biopsies the concentration of collagen and of small and large proteoglycans were determined.
 .The role of transforming growth factor-b TGF-b as a mediator of the remodelling process was also investigated. The
concentration of collagen decreased and 1 week before partus, 50% of the nonpregnant level was attained. No further
decrease was noted after partus. The mRNA for collagen I and III did, however, not decrease in the term pregnant cervix 1
week before partus. Only 20–30% decrease during the final ripening just before partus was recorded. Neither did the
mRNA levels of the small proteoglycans change significantly during the ripening, despite an almost 50% decrease in the
concentration of the small proteoglycans. The message for versican was, however, 5-fold increased at partus and then
gradually returned to nonpregnant levels within 4 days after delivery. These changes corresponded to similar changes in the
concentration of the large proteoglycan. Thus, the remodelling of the cervical connective tissue is achieved by two different
mechanisms, on one hand an increased turnover of collagen and the small proteoglycans, on the other a changed
transcription followed by an increased production of versican. During the involution 2- to 3-fold increases in the messages
for collagen I and III, and the small proteoglycans, biglycan and decorin, corresponded to increases in the concentration of
the small proteoglycans and non-extractable collagen. The message for TGF-b was increased 2-fold immediately after
delivery compared with the term pregnant state. Thus, TGF-b may be of importance for the reconstruction of the cervix,
which starts immediately after partus. q 1998 Elsevier Science B.V.
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1. Introduction
The nonpregnant human cervix consists of more
than 85% fibrous connective tissue. During preg-
nancy and parturition, an extensive remodelling of
this cervical connective tissue occurs. A well-timed
cervical ripening is essential for an uncomplicated
vaginal delivery and disturbances in this process might
w xcompromise both mother and foetus 1,2 . After de-
livery the cervix rapidly loses its extensibility and
regains a firm and inelastic consistency. How this
ripening of the cervix and the subsequent reconstruc-
tion of the tissue are accomplished and regulated are
not understood.
The main components of the cervical connective
tissue are collagen types I and III, making up 70%
w xand 30% of the cervical collagen, respectively 3 .
Furthermore, there are substantial amounts of proteo-
glycans, which are of importance for the organisation
of collagen. The dominating proteoglycan in the hu-
man cervix is a small dermatan sulphate proteogly-
w xcan, decorin 4,5 . Furthermore, a second small der-
matan sulphate proteoglycan, biglycan, a large chon-
droitin sulphate proteoglycan, a heparan sulphate pro-
teoglycan and at least two keratan sulphate proteogly-
cans have been identified and characterised in the
nonpregnant as well as in the term pregnant human
w xcervix 5,6 . Decorin and another small proteoglycan,
fibromodulin, have been shown to influence the fib-
w xrillation of collagen I and III 7–10 , whereas bigly-
w xcan does not 9 . Biglycan and the large proteoglycan,
versican, which interacts with hyaluronan, on the
contrary fill up the space between the collagen fibrils
w xand disperse them 11–13 . Thus, changes in the
concentration of these different connective tissue
components will strongly affect the qualities of the
cervical tissue.
Cervical ripening is associated with an extensive
reorganisation of the collagen network. The normal
ripening process can be separated into two, probably
differently regulated phases, one slow and one fast.
The slow remodelling starts early in pregnancy and
results in a 50–70% decrease in collagen and 50%
w xproteoglycan concentrations at term 1,5 . The final
cervical ripening process just before onset of andror
during early labour is associated mainly with an
w xincreased leukocyte collagenase concentration 14,15
and an increased proteoglycan turnover, resulting in a
changed composition of the proteoglycans in the ripe
w xcervix 16 . During the involution that starts immedi-
ately after partus the cervix quickly regains its non-
pregnant appearance and qualities. How these thor-
ough changes are accomplished, and how they are
regulated are unknown. Potential modulators of the
connective tissue remodelling during cervical ripen-
ing and involution are hormones, such as prosta-
glandins, progesterone and oestrogen, and cytokines
 .such as interleukin-8 IL-8 and transforming growth
 .factor-b TGF-b .
To reveal the regulating mechanisms behind the
breakdown and the reconstruction of the cervical
connective tissue, we have related the differential
expressions of the mRNA to the resulting extracellu-
lar matrix components and TGF-b during cervical
ripening and involution.
2. Materials and methods
2.1. Subjects
Cervical biopsies were obtained from 56 healthy
women. Seven nonpregnant, still menstruating women
were undergoing hysterectomy due to benign disor-
 .ders not involving the cervix NP . Eighteen term
pregnant women with clinically unfavourable cer-
 .vices cervical score F5 p were undergoing elective
caesarean sections because of fetopelvic dispropor-
 .tion TP and additionally 26 term pregnant women
 .experienced spontaneous vaginal deliveries PP . Five
women had a sterilisation carried out 2–4 days after a
 .spontaneous vaginal delivery at term INV . The
mean age of the nonpregnant women was 43 yrs
 .range 39–48 and that of the pregnant women 31 yrs
 .range 23–42 , without any significant difference be-
tween the different groups.
The biopsies were taken transvaginally from the
anterior cervical lip immediately after delivery or at
surgery. The mucosa was carefully excised and the
biopsy specimens were immediately immersed in liq-
uid nitrogen and stored at y708C until analysed. All
women gave their informed consent and the local
Ethics Committee of the Karolinska Hospital ap-
proved the study.
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2.2. Materials
The cDNA probes used were for collagen I and III
w xas described by Sandberg and Vuorio 17 , for bigly-
w xcan as described by Fisher et al. 18 , and for fibro-
w xmodulin as described by Oldberg et al. 19 . Other
cDNA probes used were a 1050 bp Eco R1 fragment
 .of transforming growth factor-b1 TGF-b1 cDNA
w x 20 , a 1162 bp Eco R1 insert for decorin Antonsson
.and Oldberg, unpublished and a 1300 bp Eco R1
w xfragment of versican 21 . The probe for decorin was
bovine, whereas all the others were human. 32P-
labelled probes were prepared using a random prim-
 .ing cDNA labelling kit Amersham, UK as described
w x22 . Alcian Blue was produced by Chroma
 .Germany . Polyclonal antibodies against purified hu-
man cervical decorin were raised in rabbits as de-
w xscribed 4,23 . The versican antibody, raised against
versican from bovine aorta, was obtained from
w xHeinegard et al. 23 . PDVF-P Mobilon membranes˚
for blotting were purchased from Millipore. All other
chemicals were of analytical grade.
2.3. Isolation and analysis of RNA
The tissue was homogenised in guanidinium iso-
thiocyanate for 1 min at 15 000 rpm in a Buhler knife¨
homogeniser. RNA was isolated by phenolrchloro-
w xformrisoamyl alcohol extraction 24 . Total RNA
 .25–30 mgrwell was electrophoresed on a 1%
agarose gel containing formaldehyde and transferred
to nitro-cellulose filters. After the electrophoresis, a
part of the gel was stained with ethidium bromide to
verify that equal amounts of RNA were applied in
each well. The filters were hybridised with 32P-
labelled cDNA probes overnight in 50% formamide
w xat 428C 22 and then washed sequentially with 2=
SSC 0.3 M-sodium chloride, 30 mM-sodium citrate,
.pH 7.0 containing 0.1% sodium dodecyl sulphate at
428C and then with 0.2=SSC, 0.1% sodium dodecyl
sulphate at 508C. Radioactivity was visualised using
 .Hyperfilm TM-MP Amersham, UK . The amount of
radiolabel was quantified by scanning with a video-
 .densitometric system Makab, Goteborg, Sweden or¨
a Fuji bioimaging system.
2.4. Isolation and analysis of proteoglycans
The tissue was homogenised in a Buhler knife¨
homogeniser and extracted with 4-M guanidinium
chloride, containing 0.05 M-acetate and proteinase
w xinhibitors 5 . The proteoglycans were precipitated
with Alcian Blue. The pellet was resolved in guani-
dinium chloride–propanol and the concentration of
proteoglycans estimated by the absorbance of Alcian
w xBlue at 600 nm 25 . Furthermore, the different pro-
teoglycans were separated by agarose gel elec-
w xtrophoresis 26 and quantitated by scanning the gel,
using the system described above. To further identify
the proteoglycans they were transferred to PDVF-P
membranes after electrophoresis. The filters were
w xthen digested with chondroitinase ABC 27 and
treated with antibodies to either decorin or versican.
The proteoglycans were finally visualised using a
second peroxidase conjugated swine–anti-rabbit anti-
w xbody 27 .
2.5. Collagen concentration
The biopsies were extracted with 0.5 M HAc
w xfollowed by digestion with pepsin as described 1 .
The collagen concentration in the various extracts
and in the unextractable fraction was estimated as
hydroxyproline, after being hydrolysed in 6 M HCl,
w xaccording to Stegemann and Stalder 28 .
2.6. Statistical methods
Mean values"standard error of the mean were
calculated. Wilcoxon rank-sum test was used to eval-
uate the differences between groups.
3. Results
3.1. Collagen
The degree of cervical ripeness was evaluated by
collagen concentration and collagen extractability af-
w xter digestion with pepsin 1 . In comparison with the
nonpregnant cervix, the collagen concentration was
significantly decreased in the unfavourable, term
pregnant cervix. It was then even further decreased in
the biopsies obtained immediately after spontaneous
 .vaginal delivery Fig. 1 . The extractability was simi-
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Fig. 1. Expression of collagen and mRNA for collagen I and III in biopsies from human cervix at different stages of pregnancy. Cervical
 .  .biopsies were taken from nonpregnant women NP , term pregnant women TP , women immediately after spontaneous vaginal delivery
 .  .PP , and from women 2–4 days postpartum INV . Collagen concentration and the amount of collagen not extracted by pepsin digestion
w xwere measured as hydroxyproline according to Bjonsson 27 . The results represent mean values"standard error of the mean. Total RNA¨
was isolated and separated by electrophoresis on a 1% agarose gel as described in Section 2. Staining the gels with ethidium bromide
indicated that the same amount of RNA was applied in all lanes. After Northern blots to nylon filters, hybridisations were performed with
32P-labelled cDNA probes for collagen I and III. The migration of 18S and 28S rRNA are indicated. The components were quantified by
scanning the Northern blots. The sum of the two messages for collagen I and III are represented as mean values"standard error of the
mean.
larly significantly increased at term and then some-
what further increased after optimal spontaneous
ripening, as observed in the biopsies obtained imme-
diately after vaginal delivery. Four days after partus a
significant increase in the amount of collagen non-ex-
tractable after pepsin digestion was observed. These
changes correspond well to the changes in the consis-
tency of the cervix noticed clinically.
Despite these large changes at term pregnancy no
changes in the mRNAs for collagen I and III as well
 .as total RNA of the tissue Table 1 compared to
nonpregnant cervix were observed. However, in the
biopsies obtained immediately after spontaneous
vaginal delivery the message for collagen I had de-
creased to 60%"8 of that in the nonpregnant cervix
 .ps0.03 . The corresponding values for collagen III
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Table 1
 .  . The concentrations of small proteoglycans PGS , versican and heparan sulphate proteoglycans HSPG , and total RNA mean"standard
.error of the mean
Group PGS Versican HSPG RNA
 .  .  .  .mgrmg of wet weight mgrmg of wet weight mgrmg of wet weight mgrmg of wet weight
 .  .Nonpregnant ns5 2.69"0.22 70.05"0.040 0.10"0.030 0.847"0.07 ns9
 .  .Term pregnant ns15 1.53"0.053 0.18"0.033 0.13"0.032 0.712"0.19 ns9
 .p vs. nonpregnant 0.008 0.035 ns ns
 .  .Vaginally delivered ns24 1.01"0.070 0.19"0.025 0.24"0.040 0.67"0.09 ns7
 .p vs. nonpregnant 0.0009 0.031 0.027 ns
 .p vs. term pregnant 0.0000008 ns 0.027 ns
 .  .Involution ns4 2.13"0.435 0.13 0.11 0.915"0.26 ns2
 .p vs. nonpregnant ns ns ns ns
 .p vs. vaginally delivered 0.084 ns ns ns
Proteoglycans were measured by scanning of the gels after agarose gel electrophoresis, using decorin as standard. Total RNA was
estimated by absorption measurements.
nssnot significant at p)0.05.
 .was 59%"18 ps0.008 . During involution the
messages then increased. In biopsies taken two days
after delivery the messages were 2.5-fold and 3.5-fold,
respectively, the values in the nonpregnant cervix
 .Fig. 1 .
3.2. Proteoglycans
The proteoglycan content of nonpregnant, term-
pregnant and postpartal cervical tissue has earlier
been shown to mainly consist of decorin. Less than
10% of the proteoglycans of nonpregnant cervix are
constituted by biglycan, heparan sulphate proteogly-
cans and a large chondroitin sulphate proteoglycan
w x5 . The main changes occurring towards partus are a
decrease in decorin concentration and an increase in
the large chondroitin sulphate proteoglycan concen-
w xtration 16 . These findings concerning the major
proteoglycans are confirmed in this communication
by purification with Alcian Blue followed by agarose
gel electrophoresis and identification by specific
degradation with chondroitinases and antibodies di-
Fig. 2. Agarose electrophoresis of proteoglycans and their subsequent identification with antibodies to versican and decorin. Cervical
biopsies were taken from nonpregnant and term pregnant women and from women immediately after spontaneous vaginal delivery and 4
days postpartum. The biopsies were extracted with guanidinium chloride and the proteoglycans were purified using Alcian Blue and then
separated by electrophoresis on 2% agarose gels. The proteoglycans were visualised with Alcian Blue or after blotting and chondroitinase
ABC digestion and treatment with antibodies against decorin or versican and with a second antibody conjugated with peroxidase using
 .  .  .3,3-diaminobenzidine as substrate. Large proteoglycans PGL , heparan sulphate proteoglycans HSPG and small proteoglycans PGS .
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Fig. 3. Northern blots of biglycan and decorin and expression of small proteoglycans in human cervical biopsies at different stages of
pregnancy. Cervical biopsies were obtained from nonpregnant and term pregnant women, and from women immediately after spontaneous
vaginal delivery and 2 to 4 days postpartum. Total RNA was isolated and hybridised with 32P-labelled cDNA probes for biglycan and
decorin and further quantified as described in Section 2. The concentrations of small proteoglycans were determined after agarose gel
electrophoresis by scanning and integrating the gels using decorin from bovine sclera as standard. The data represent mean
values"standard error of the mean.
rected to various proteoglycans. The proteoglycans
were separated into three different components by
 .agarose gel electrophoresis Fig. 2 . The larger pro-
teoglycans were degraded by chondroitinase ABC
 .data not shown , and after blotting followed by
digestion with chondroitinase ABC. By treating the
filter with an antibody against decorin, the large
chondroitin sulphate proteoglycan could for the first
Fig. 4. Northern blots of fibromodulin in biopsies from human cervix at different stages of pregnancy. Biopsies were obtained from
nonpregnant and term pregnant women and from women immediately after spontaneous vaginal delivery and 2 days postpartum. Total
RNA was isolated, hybridised with 32P-labelled probes for fibromodulin and decorin, and quantified as described in Section 2. The results
represent mean values"standard error of the mean.
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 .time be identified as versican Fig. 2 . The small
proteoglycans could be identified by digestion with
 .chondroitinase ABC data not shown and antibody
against decorin, after blotting and chondroitinase
 .ABC-digestion Fig. 2 . The intermediate sized pro-
teoglycans were not degraded by chondroitinase ABC
 .data not shown and, therefore, considered to be
heparan sulphate proteoglycans.
The concentration of small proteoglycans deter-
mined by scanning of Alcian-Blue-stained elec-
 .trophoretogram Fig. 3 or by staining with antibodies
 .against decorin Fig. 2 was highest in the nonpreg-
 .nant tissue and decreased during pregnancy Table 1 .
The lowest concentration, 50% of the nonpregnant
level was seen in the optimally ripened cervix imme-
diately after spontaneous vaginal delivery. In both
nonpregnant and pregnant cervical connective tissue
decorin is the dominating proteoglycan, however, the
proportion of biglycan increases from 5% to 13% of
the small proteoglycans in the term pregnant cervix
w xcompared with the nonpregnant one 5 . In spite of
the large decrease in decorin concentration the rela-
tive proportion of mRNA for decorin to total RNA
 .Table 1 was unchanged during pregnancy and par-
 .turition Fig. 3 . The message for biglycan was de-
creased compared to total RNA in the term pregnant,
clinically unripe cervix, to 0.7"0.2 compared to the
 .  .nonpregnant values ps0.025 Fig. 3 . This de-
crease in mRNA did, however, not correspond to
changes in the concentration of biglycan in the tissue
w x5 . Possible small increases were noted for biglycan
and decorin in the biopsies obtained immediately
after optimal cervical ripening in comparison with the
term pregnant, still unripe cervix. Two to four days
after delivery increases in the messages for both
biglycan, 1.4-fold, and decorin, 1.6-fold compared to
nonpregnant cervix, were registered. The concentra-
tion of small proteoglycans accordingly increased
2.1-fold compared to the conditions at partus Table
.1 . Due to the difficulty of getting biopsies from this
category of patients it was impossible to make any
statistical evaluation of these data.
Besides the mRNA for biglycan and decorin, we
could also identify the mRNA of fibromodulin, a
third member of the family of small proteoglycans, in
both nonpregnant and pregnant human cervix Fig.
.4 . This proteoglycan has not earlier been described
in the human cervical connective tissue. On the con-
trary to decorin and biglycan, the message for fibro-
modulin increased significantly compared to total
RNA in the term pregnant, clinically unripe cervix, to
 .1.5"0.1 of the nonpregnant values Fig. 4 . The
Fig. 5. Northern blots and expression of versican in human
cervical biopsies at different stages of pregnancy. Biopsies were
taken from nonpregnant and term pregnant women and from
women immediately after spontaneous vaginal delivery and 2 to
4 days postpartum. Total RNA was isolated and hybridised with
32P-labelled probes for versican and quantified as described
Section 2. The concentration of versican was determined after
agarose gel electrophoresis by scanning and integrating the gels
using decorin from bovine sclera as standard. The results repre-
sent mean values"standard error of the mean.
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Fig. 6. Northern blots of TGF-b in biopsies from human cervices at different stages of pregnancy. Biopsies were obtained from
nonpregnant and term pregnant women and from women immediately after spontaneous vaginal delivery and 2 to 4 days postpartum.
Total RNA was isolated and hybridised with 32P-labelled probes for TGF-b and quantified as described in Section 2. The results
represent mean values"standard error of the mean.
mRNA-level for fibromodulin did not change during
the first two days of cervical involution.
In contrast to the mRNA for collagens and small
proteoglycans, the mRNA for versican increased dur-
ing pregnancy. In the unripe cervix at term there was
a 1.5-fold increase, compared with the nonpregnant
 .cervix Fig. 5 . Then, a more marked increase oc-
curred during the final cervical ripening, 3.4-fold in
comparison with the unripe, term pregnant cervices
 ps0.047, and ps0.009 compared with nonpreg-
.nant cervix . During involution the concentration of
versican mRNA at day 4 had decreased nearly to that
 .of the nonpregnant cervix Fig. 5 . The concentration
of versican determined by scanning the gels after
 .agarose gel electrophoresis Figs. 2 and 5, Table 1
was in accordance with the changes of mRNA. It was
very low in the nonpregnant tissue. It increased dur-
ing pregnancy and the highest concentration was seen
in the ripe cervix immediately after vaginal delivery,
subsequently the concentration decreased again dur-
ing the involution. Also the concentration of heparan
sulphate proteoglycans increased approximately 2-
 .fold at partus Table 1 .
3.3. TGF-b
The level of mRNA for growth factor TGF-b was
slightly lower in the unripe cervix at term compared
 . to that in the nonpregnant cervix ps0.004 Fig.
.6 . In cervical biopsies obtained immediately after
partus a clear increase of 2.3-fold was noticed ps
.0.011 . In comparison with the nonpregnant cervical
 .specimens the increase was 1.8"0.3 ps0.011 .
During involution the levels of mRNA for TGF-b
 .returned to nonpregnant levels Fig. 6 .
4. Discussion
During cervical ripening and involution, major
changes in the mRNA-levels and the concentrations
of the corresponding extracellular matrix components
occur. At term pregnancy the main findings are a
substantial decrease in the concentration of collagen
and proteoglycans without any corresponding change
in the mRNA compared to total RNA for these
components. After optimal spontaneous ripening a
significant increase in versican and decreases in col-
lagen concentrations correspond to similar changes in
the mRNA for the respective component. At involu-
tion, a complete different situation appears with con-
siderable increases in the mRNA for decorin, bigly-
can and collagen I and III, corresponding to increases
in the concentration of small proteoglycans and the
amount of non-extractable collagen, while the con-
centration as well as the mRNA for versican de-
creases. These changes correspond to the physical
changes of the cervix.
During pregnancy a 50-70% decrease in the colla-
w xgen concentration 1,5,16 and a 40–50% decrease in
w xthe concentration of decorin occur 1,16 . However,
no significant decrease in the mRNA for collagen I
and III and decorin were registered. Furthermore, by
studying the incorporation of 35SO into proteogly-4
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cans, 2- to 3-fold increases in the synthesis have been
w xnoted at term 5 . These discrepancies may have
several different explanations. It could easily be ex-
plained by a increase in volume of the cervix as
w x w xoccurs both in the rat 29 and in the sheep 30 . An
increase in volume is likely to be accompanied by a
decrease in the concentration of extracellular matrix
component even if synthesis is increased and
mRNA-levels unchanged. However, using methods
like palpation and ultrasound, it is clinically accepted
that cervix volume increase by maximally 20–30%.
If these estimations are correct, collagen as well as
proteoglycans decrease both in concentration as well
as in total mass.
The mRNA estimations can also be regarded as
doubtful as it is shown that white blood cells espe-
cially neutrophils invade the cervical tissue at term
w xand partus 1,31 . In this study, we have applied the
same amount of RNA for electrophoresis. Further-
more, there is no general increase in total RNA
 .content per wet weight Table 1 .
Thus, there are two possible explanations for the
data obtained; one is an increase of cervical tissue,
the other a remodelling based on increased turnover,
i.e., synthesis and degradation, of collagen and pro-
teoglycans. The latter hypothesis is at least partly
supported by clinical estimations indicating that only
a slight increase of around 20–30% of cervical vol-
ume occurs. Furthermore, the large increase in a
DNP-peptidase, which may be identical to
stromelysin, as well as collagen during the same
w xperiod 1 also supports the idea of an increased
turnover of cervical extracellular matrix. Finally, the
responses shortly after partus with increased content
of mRNA compared to total RNA for collagen I, III,
and decorin also supports this hypothesis. Thus, an
increased degradation of proteoglycans in combina-
tion with a high synthesis may be of importance to
achieve a sufficient remodelling of the cervical con-
nective tissue to yield a ripe cervix at parturition.
Final evidence must await more data concerning cer-
vical volume, presence of inflammatory cells in the
cervix, expression of mRNA expression and activities
of various relevant metalloproteinases during the re-
modelling phase.
In contrast to the mRNA for decorin and biglycan
a several-fold increase in the mRNA for versican
occurred during cervical ripening. A corresponding
increase in the concentration of a large proteoglycan,
for the first time identified as versican by agarose gel
electrophoresis and Western blotting, was recorded.
Earlier an increased amount of a large proteoglycan
and an increased incorporation of 35SO into this4
proteoglycan have been noted in the ripe cervix
obtained immediately after spontaneous vaginal de-
w xlivery 16 . It was however not identified as versican.
Thus, versican is differently metabolised compared to
w xthe small dermatan sulphate proteoglycans 7 . The
changes of the recently described keratan sulphate
proteoglycans during pregnancy remain to be de-
scribed. mRNA for fibromodulin, which also is a
keratan sulphate proteoglycan, increases, however, in
term pregnant cervix.
The collagen fibrils play a major role for the
w xmechanical properties of the cervix 32 . Both the
appearance and the organisation of these fibrils differ
considerably in the ripe cervix compared with the
nonpregnant one. This change in organisation is
caused by a changed turnover of the tissue, resulting
in different cross-link organisation of the collagens,
and changes in the composition of the extracellular
matrix, mainly proteoglycans, surrounding the fibrils.
In several systems proteoglycans have been shown to
w xinteract specifically with the collagen fibrils 6 .
Decorin and fibromodulin interact with and modify
w xthe fibrils 8 , whereas others, i.e., biglycan and
versican, fill up the space between the fibrils and
rather tend to disperse them. In particular, the struc-
ture of versican, having 12–15 chondroitinrdermatan
sulphate side chains, and its ability to form large
w xaggregates with hyaluronan 11–13 are of impor-
tance for immobilising water and thereby increasing
the swelling pressure between the collagen fibrils.
Biglycan may interact with decorin via the side-chains
w x33 and thus interfere with the collagen fibrillation.
Thus, during the remodelling of the cervical connec-
tive tissue, the decrease of concentration of decorin
and the increase in concentration of versican should
be of major importance for changing the organisation
of the collagen fibrils to form a ripe cervix. The
two-fold increase in concentration of heparan sul-
phate proteoglycans at partus is obscure. The inter-
pretation of this increase must await identification of
the particular heparan sulphate proteoglycan. Further-
more, its localisation must be determined.
To enable a smooth passage of the foetus a final,
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quick cervical remodelling is of major importance.
This may be accomplished by an increase in collage-
w xnase, depolarising the collagen network 34,14,15 , in
combination with an increase in the concentration of
versican, which also influences the collagen network.
The increases in the mRNA compared to total
RNA for decorin and collagens and the correspond-
ing increases in the concentration of small proteogly-
cans and non-extractable collagen, noted during invo-
lution, agree well with the reconstruction of the
cervical connective tissue that starts immediately af-
ter partus. The same is valid for the decrease in the
mRNA as well as the concentration of versican. The
increase in the mRNA for biglycan and the decreased
message for fibromodulin are, however, more diffi-
cult to explain and require further insight into the
organisation of different types of connective tissues.
The regulating mechanisms of the cervical ripen-
ing process are still virtually unknown. It is, how-
ever, likely that progesterone and oestrogen are im-
w xportant for the remodelling of the human cervix 35 .
The final quick remodelling at partus is probably
mediated by IL-8, present in the human cervix just
w xaround partus 36 . Its major role is to attract neu-
w xtrophils 37,31 , which secrete elastase and collage-
nase of central importance for the remodelling around
w xpartus 1 . Furthermore, it may be of importance in
the regulation of collagen turnover as it has been
demonstrated to have the ability to inhibit collagen
w xexpression 38 . Other cytokines such as IL-1, which
is a major mediator of tissue degradation and remod-
elling in inflammatory diseases is also involved and
w xmay be one of the inducers of IL-8 39 . The message
for TGF-b is increased in the tissue obtained at
spontaneous vaginal delivery. This increase is fol-
lowed by the increases in the messages for decorin,
biglycan and collagen I and III during the first days
postpartum. This indicates that TGF-b is involved in
the reconstruction of the cervical connective tissue
during the involution. However, in most tissues TGF-
b induces decreases in decorin and increases in
biglycan and versican, both messages and expressions
w x40,41 . Furthermore, the decorin promoter contains a
w xTGF-b negative response element 42 . This indi-
cates that also other cytokines must be involved in
the cervical involution process. Further studies with
these cytokines and hormones are therefore of impor-
tance to gain increased insight in the control and
thereby the clinical management of the cervical ripen-
ing process.
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